Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports

@article{Alper2007SeizureII,
  title={Seizure Incidence in Psychopharmacological Clinical Trials: An Analysis of Food and Drug Administration (FDA) Summary Basis of Approval Reports},
  author={Kenneth Robert Alper and Kelly A. Schwartz and Russell L. Kolts and Arif Khan},
  journal={Biological Psychiatry},
  year={2007},
  volume={62},
  pages={345-354}
}
BACKGROUND Clinical trial data provide an approach to the investigation of the effects of psychopharmacological agents, and psychiatric disorders themselves, on seizure threshold. METHODS We accessed public domain data from Food and Drug Administration (FDA) Phase II and III clinical trials as Summary Basis of Approval (SBA) reports that noted seizure incidence in trials of psychotropic drugs approved in the United States between 1985 and 2004, involving a total of 75,873 patients. We… CONTINUE READING
BETA

Citations

Publications citing this paper.
SHOWING 1-10 OF 113 CITATIONS, ESTIMATED Infinity% COVERAGE

113 Citations

051015'09'12'15'18
Citations per Year
Semantic Scholar estimates that this publication has 113 citations based on the available data.

See our FAQ for additional information.

References

Publications referenced by this paper.
SHOWING 1-10 OF 123 REFERENCES

Anticonvulsant effects of acute and repeated fluoxetine treatment in unstressed and stressed mice

  • TV Perneger
  • Brain Res
  • 2005

Similar Papers

Loading similar papers…